We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+15.78%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$214M
AUM Growth
+$8.02M
(+3.9%)
Cap. Flow
-$25.4M
Cap. Flow
% of AUM
-11.88%
Top 10 Holdings %
Top 10 Hldgs %
48%
Holding
93
New
17
Increased
13
Reduced
25
Closed
14
Top Buys
| 1 |
VYNE Therapeutics
VYNE
|
+$3.37M |
| 2 |
Indaptus Therapeutics
INDP
|
+$2.82M |
| 3 |
Kura Oncology
KURA
|
+$1.91M |
| 4 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$1.63M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$1.38M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$3.44M |
| 2 |
argenx
ARGX
|
+$2.88M |
| 3 |
Insulet
PODD
|
+$2.82M |
| 4 |
Rigel Pharmaceuticals
RIGL
|
+$2.72M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$2.04M |
Sector Composition
| 1 | Healthcare | 85.47% |
| 2 | Financials | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $27.5M | 12.89% |
158,675
-22,862
| -13% | -$3.44M |
|
|
SAGE
2
DELISTED
Sage Therapeutics
SAGE
| $15M | 7.04% |
96,000
+2,000
| +2% | +$314K |
|
3
Stereotaxis
STXS
$161M
| $10.5M | 4.93% |
13,680,554
| – | – |
|
|
AERI
4
DELISTED
Aerie Pharmaceuticals
AERI
| $8.9M | 4.17% |
131,770
-1,000
| -0.8% | -$56K |
|
|
NXTM
5
DELISTED
NxStage Medical Inc.
NXTM
| $8.54M | 4% |
306,119
| – | – |
|
6
AtriCure
ATRC
$1.75B
| $8.53M | 3.99% |
315,345
-73,800
| -19% | -$1.73M |
|
|
ALDR
7
DELISTED
Alder Biopharmaceuticals
ALDR
| $6.26M | 2.93% |
396,013
| – | – |
|
8
Akebia Therapeutics
AKBA
$370M
| $6.09M | 2.85% |
610,738
| – | – |
|
|
BPMC
9
DELISTED
Blueprint Medicines
BPMC
| $5.88M | 2.76% |
92,691
+4,000
| +5% | +$318K |
|
10
DexCom
DXCM
$28.6B
| $5.22M | 2.45% |
220,000
-80,000
| -27% | -$1.7M |
|
|
LMNX
11
DELISTED
Luminex Corp
LMNX
| $5.02M | 2.35% |
169,891
-57,609
| -25% | -$1.48M |
|
12
Ascendis Pharma A/S
ASND
$17.5B
| $4.91M | 2.3% |
73,745
-5,500
| -7% | -$362K |
|
13
Neurocrine Biosciences
NBIX
$17.2B
| $4.47M | 2.09% |
45,508
-9,000
| -17% | -$806K |
|
|
14
Kura Oncology
KURA
$1B
| $4.36M | 2.04% |
239,500
+112,500
| +89% | +$1.91M |
|
|
IMMU
15
DELISTED
Immunomedics Inc
IMMU
| $4.33M | 2.03% |
183,000
-97,900
| -35% | -$1.97M |
|
|
ZGNX
16
DELISTED
Zogenix, Inc.
ZGNX
| $4.32M | 2.02% |
97,764
+3,500
| +4% | +$144K |
|
|
ARNA
17
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.15M | 1.94% |
95,242
-31,500
| -25% | -$1.35M |
|
|
CBAY
18
DELISTED
Cymabay Therapeutics
CBAY
| $3.95M | 1.85% |
294,511
-29,332
| -9% | -$367K |
|
|
LKFT
19
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $3.74M | 1.75% |
40,609
+1,000
| +3% | +$97K |
|
|
20
BioCryst Pharmaceuticals
BCRX
$2.41B
| $3.46M | 1.62% |
604,652
-370,000
| -38% | -$2.04M |
|
21
iShares Biotechnology ETF
IBB
$9.23B
| $2.87M | 1.34% |
26,100
| – | – |
|
22
Xenon Pharmaceuticals
XENE
$6.55B
| $2.71M | 1.27% |
294,362
-83,333
| -22% | -$518K |
|
|
ACHN
23
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.68M | 1.26% |
947,636
+79,364
| +9% | +$270K |
|
|
VBIV
24
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $2.57M | 1.2% |
31,156
-2,111
| -6% | -$204K |
|
|
25
VYNE Therapeutics
VYNE
$25.6M
| $2.53M | 1.19% |
+4,333
| New | +$3.37M |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML